- Home
- ESPR vs GDEV Comparison
ESPR vs GDEV Comparison
Compare ESPR & GDEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- GDEV
- Stock Information
- Founded
- ESPR 2008
- GDEV 2009
- Country
- ESPR United States
- GDEV Cyprus
- Employees
- ESPR N/A
- GDEV N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- GDEV EDP Services
- Sector
- ESPR Health Care
- GDEV Technology
- Exchange
- ESPR Nasdaq
- GDEV Nasdaq
- Market Cap
- ESPR 305.0M
- GDEV 333.8M
- IPO Year
- ESPR 2013
- GDEV N/A
- Fundamental
- Price
- ESPR $1.69
- GDEV $15.24
- Analyst Decision
- ESPR Buy
- GDEV Buy
- Analyst Count
- ESPR 7
- GDEV 2
- Target Price
- ESPR $6.36
- GDEV $70.00
- AVG Volume (30 Days)
- ESPR 4.2M
- GDEV 33.5K
- Earning Date
- ESPR 03-04-2025
- GDEV 04-01-2025
- Dividend Yield
- ESPR N/A
- GDEV N/A
- EPS Growth
- ESPR N/A
- GDEV N/A
- EPS
- ESPR N/A
- GDEV 2.04
- Revenue
- ESPR $332,314,000.00
- GDEV $432,534,000.00
- Revenue This Year
- ESPR $5.51
- GDEV N/A
- Revenue Next Year
- ESPR $1.42
- GDEV $9.01
- P/E Ratio
- ESPR N/A
- GDEV $7.45
- Revenue Growth
- ESPR 185.66
- GDEV N/A
- 52 Week Low
- ESPR $1.47
- GDEV $14.26
- 52 Week High
- ESPR $3.94
- GDEV $42.76
- Technical
- Relative Strength Index (RSI)
- ESPR 49.78
- GDEV 41.01
- Support Level
- ESPR $1.47
- GDEV $14.43
- Resistance Level
- ESPR $1.61
- GDEV $19.50
- Average True Range (ATR)
- ESPR 0.12
- GDEV 0.89
- MACD
- ESPR 0.02
- GDEV -0.30
- Stochastic Oscillator
- ESPR 56.41
- GDEV 15.54
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.